On the front lines – Managing CRS in the Emergency Department

by Michael Fenimore | Dec 3, 2025 | Emergency Medicine, Oncology

Rigorous clinical research has led to the discovery of novel immunologic therapies. Chimeric antigen receptor T cell (CAR T-cell) therapy has shown impressive outcomes but is associated with a significant risk of adverse events (AEs), chiefly cytokine release syndrome...

Addressing the Challenges in the Multidisciplinary Care of Patients with High-Risk NMSC

by Michael Fenimore | Dec 3, 2025 | Dermatology, Oncology

Non-melanoma skin cancers (NMSC) represent a class of heterogeneous cutaneous malignancies including basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), Merkel cell carcinoma (MCC), and rarer skin cancers.

Optimizing and Individualizing CIDP Treatment

by Michael Fenimore | Dec 3, 2025 | Neurology

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a progressive immune-mediated disorder of the peripheral nerves attributed to demyelination and impairment of signal conduction in motor and/or sensory nerves.

Navigating Real-World Issues in the Management of Eosinophilic Esophagitis

by Michael Fenimore | Dec 3, 2025 | Allergy and Immunology, Pediatrics, Pharmacy

This curriculum provides practical guidance on the diagnosis and management of eosinophilic esophagitis (EoE), a chronic, immune-mediated disease of the esophagus with rising prevalence. Learners will engage with current diagnostic algorithms, examine treatment...

The Evolving Landscape of GEP-NETs – From Precise Staging to Novel Treatments and Coordinated Care

by Michael Fenimore | Dec 3, 2025 | Endocrinology, Hematology-Oncology, Oncology

This program is designed to provide you with the latest strategies for accurately diagnosing, staging, and treating GEP-NETs by integrating pathological grading with advanced imaging and novel systemic therapies. This activity emphasizes a collaborative approach,...